Диссертация (1141140), страница 32
Текст из файла (страница 32)
– 2014. – Vol. 114, № 12. – P. 2459-2568.111. Avital, A. Contrasting roles of corticosteroid receptors in hippocampal plasticity /A. Avital, M. Segal, G. Richter-Levin //J. Neurosci. – 2006. – Vol. 26, № 36. – P. 91309134.112. Baeza, I. Improvement of leucocyte functions in ovariectomised aged rats aftertreatment with growth hormone, melatonin, oestrogens or phyto-oestrogens / I. Baeza,C.
Alvarado, P. Alvarez [et al.] // J. Reprod. Immunol. – 2009. – Vol. 80, №1-2. – P.70-79.113. Banks, W.A. Entry of blood-borne cytokines into the central nervous system:effectsoncognitiveprocesses/W.A.Banks,S.A.Farr,J.E.Morley//Neuroimmunomodulation. – 2003. – Vol. 10, № 6. – P. 319-327.114.
Banks, G. Genetic background influences age-related decline in visual andnonvisual retinal responses, circadian rhythms, and sleep / G. Banks, I. Heise, B.Starbuck [et al.] // Neurobiol. Aging. – 2015. – Vol. 36, № 1. – P. 380-393.115. Banks, W.A. The blood-brain barrier and immune function and dysfunction /W.A. Banks, M.A. Erickson // Neurobiol. Dis. – 2010.
–Vol. 37, № 1. – Р. 26-32.116. Barbini, B. Dark therapy for mania: a pilot study / B. Barbini, F. Benedetti, C.Colombo [et al.] // Bipolar. Disord. – 2005. – Vol. 7, № 1. – P. 98-101.117. Barnard, А.R. When Clocks Go Bad: Neurobehavioural Consequences ofDisrupted Circadian Timing [Electronic resource]/ А.R. Barnard, Nolan P.M. // PLoSGenet.–2008.–Vol.4,№5.–Modeofaccesshttp://www.ncbi.nlm.nih.gov/pmc/articles/PMC2295261/pdf/pgen.1000040.pdf/of access: 19.09.2015).:(Date203118.
Barrientos, R.M. Memory for context is impaired by a post context exposureinjection of interleukin-1 beta into dorsal hippocampus / R.M. Barrientos, E.A. Higgins,D.B. Sprunger // Behavioural brain research. – 2002. – Vol. 134, № 1-2. –P. 291–298.119. Bavithra, S. Effect of Melatonin on Glutamate: BDNF Signaling in the CerebralCortex of Polychlorinated Biphenyls (PCBs)-Exposed Adult Male Rats / S.
Bavithra, E.Sugantha Priya, K. Selvakumar [et al.] // Neurochem. Res. – 2015. – Vol. 40, № 9. –P.1858-1869.120. Becker-Andre, M. Pineal gland hormone melatonin binds and activates an orphanof the nuclear receptor superfamily / M. Becker-Andre, I. Wiesenberg, N.
SchaerenWiemers // J. Biol. Chem. – 1994. – Vol. 269, № 46. – P. 28531–28534.121. Bell-Pedersen, D. Circadian rhythms from multiple oscillators: lessons fromdiverse organisms / D. Bell-Pedersen, V.M. Cassone, D.J. Earnest [et al.] // Nat. Rev.Genet. – 2005. – Vol. 6, № 7. – P. 544-556.122. Bhatti, P. Nightshift work and genome-wide DNA methylation / P.
Bhatti, Y.Zhang, X. Song [et al.] // Chronobiol. Int. – 2015. – Vol. 32, № 1. – P. 103-112.123. Blask, D.E. Melatonin as a chronobiotic/anticancer agent: cellular, biochemical,and molecular mechanisms of action and their implications for circadian-based cancertherapy / D.E. Blask, L.A. Sauer, R.T. Dauchy // Curr. Top. Med. Chem. – 2002. – Vol.2, № 2. – P. 113-132.124. Boivin, D.B. Impacts of shift work on sleep and circadian rhythms / D.B. Boivin,P. Boudreau // Pathol. Biol.
– 2014. – Vol. 62, № 5. – P. 292-301.125. Bonmati-Carrion, M.A. Protecting the Melatonin Rhythm through CircadianHealthy Light Exposure / M.A. Bonmati-Carrion, R. Arguelles-Prieto, M.J. MartinezMadrid [et al.] // Int. J. Mol. Sci. – 2014. – Vol. 15, № 12. – P. 23448-23500.126. Borjigin, J. Circadian Regulation of Pineal Gland Rhythmicity / J. Borjigin, L. S.Zhang, A.A. Calinescu // Mol.
Cell Endocrinol. – 2012. – Vol. 349, № 1. –P. 13–19.127. Boutin, J.A. Molecular tools to study melatonin pathways and actions / J.A.Boutin, V. Audinot, G. Ferry [et al.] // Trends Pharmacol. Sci. – 2005. – Vol. 26, № 8. –412-419.204128. Brainard, G.C. Photons, clocks, and consciousness / G.C. Brainard, J.P. Hanifin //J. Biol.
Rhythms. — 2005. — Vol. 20. — P. 314–325.129. Bromundt, V. Cajochen Circadian sleep-wake cycles, well-being, and lighttherapy in borderline personality disorder / V. Bromundt, A. Wirz-Justice, C. Kyburz [etal.] // J. Pers. Disord. – 2013. –Vol. 27, № 5. – P. 680-696.130. Brown, S.A. Circadian rhythms.
A new histone code for clocks? // Science. –2011. – Vol. 333, № 6051. – P. 1833-1834.131. Brudnowska, J. Night shift work and cancer risk: a literature review / J.Brudnowska, B. Pepłońska // Med. Pr. – 2011. – Vol. 62, № 3. – P. 323-338.132. Brzozowska, I. Mechanisms of esophageal protection, gastroprotection and ulcerhealing by melatonin. implications for the therapeutic use of melatonin ingastroesophageal reflux disease (GERD) and peptic ulcer disease / I. Brzozowska, M.Strzalka, D.
Drozdowicz [et al.] // Curr. Pharm. Des. – 2014. – Vol. 20, № 30. – P.4807-4815.133. Bubenik, G.A. Gastrointestinal melatonin: localization, function, and clinicalrelevance // Dig Dis Sci. – 2002. – Vol. 47 (10). – P. 2336-2348.134. Buijs, R.M. Organization of circadian functions: interaction with the body / R.M.Buijs, F.A. Scheer, F. Kreier [et al.] // Prog.
Brain Res. – 2006. – Vol. 153. – P. 341360.135. Burke, T.M. Combination of light and melatonin time cues for phase advancingthe human circadian clock / T.M. Burke, R.R. Markwald, E.D. Chinoy [et al.] / Sleep. –2013. – Vol. 36, № 11. – P. 1617-1624.136. Cabrera, J. Melatonin decreases cell proliferation and induces melanogenesis inhuman melanoma SK-MEL-1 cells / J. Cabrera, G. Negrín, F. Estévez [et al.] // J.Pineal.
Res. – 2010. – Vol. 49, № 1. – P.45-54.137. Cagnacci, Influences of melatonin administration on the circulation of women /A. Cagnacci, S. Arangino, M. Angiolucci //A. Am. J. Physiol. – 1998. – Vol. 274, № 2,Pt 2. – P. 335-338.205138. Cagnacci, A. Prolonged melatonin administration decreases nocturnal bloodpressure in women / A. Cagnacci, M.
Cannoletta, A. Renzi [et al.] // Am. J. Hypertens.– 2005. – Vol. 18, № 12, Pt 1. – P. 1614-1618.139. Cajochen, C. Alerting effects of light // Sleep Med. Rev. –2007. –Vol. 11, № 6. –Р. 453-464.140. Cajochen, C. Role of melatonin in the regulation of human circadian rhythms andsleep // C. Cajochen, K. Krauchi, A.
Wirz-Justice / J. Neuroendocrinol. – 2003. –Vol.15 – P. 432–437.141. Calvo, J.R. Immunomodulatory role of melatonin: specific binding sites in humanand rodent lymphoid cells / J.R. Calvo, M. Raffi-El-Indrissi, D. Pozo [et al.] // J. Pineal.Res. – 1995. – Vol. 18. – P.119–126.142. Campeau, S. Stress modulation of cognitive and affective processes / S.Campeau, I. Liberzon, D.
Morilak [et al.] // Stress. – 2011. – Vol. 14, № 5. – P.503-519.143. Campino, C. Melatonin reduces cortisol response to ACTH in humans / C.Campino, F. Valenzuela, E. Arteaga [et al.] // Rev. Med. Chil. –2008. –Vol. 136, № 11.– P. 1390-1397.144. Cannon, C.P. Circadian variation in the onset of unstable angina and non-Q-waveacute myocardial infarction (the TIMI III Registry and TIMI IIIB) / C.P. Cannon, C.H.McCabe, P.H. Stone [et al.] // Am. J.
Cardiol. – 1997. – Vol. 79, № 3. – P. 253–258.145. Capelli, E. Evaluation of gene expression in human lymphocytes activated in thepresence of melatonin / E. Capelli, I. Campo, S. Panelli // Int. Immunopharmacol. –2002. – Vol. 2, № 7. – P. 885-892.146. Capuron, L. Immune system to brain signaling: neuropsychopharmacologicalimplications. / L. Capuron, A.H. Miller // Pharmacol. Ther. – 2011. – Vol.
130, № 2. –P. 226-238.147. Cardinali, D.P. Melatonin effects on bone: experimental facts and clinicalperspectives / D.P. Cardinali, M.G. Ladizesky, V. Boggio [et al.] // J. Pineal. Res. –2003. – Vol. 34, № 2. – P. 81-87.206148. Carrillo-Vico, A. The modulatory role of melatonin on immune responsiveness /A. Carrillo-Vico, R.J. Reiter, P.J.
Lardone [et al.] // Curr. Opin. Investig Drugs. – 2006.– Vol. 7, № 5. – P. 423-431.149. Castanon-Cervantes, O. Dysregulation of inflammatory responses by chroniccircadian disruption / O. Castanon-Cervantes, M. Wu, J.C. Ehlen [et al.] //J. Immunol. –2010. – Vol.185, № 10. – P.
5796-5805.150. Cavadini, G. TNF-{alpha} suppresses the expression of clock genes byinterfering with E-box-mediated transcription / G. Cavadini, S. Petrzilka, P. Kohler [etal.] // Proc. Natl. Acad. Sci. USA. – 2007. – Vol. 104, № 31. – P. 12843-12848.151. Cawley, N.
Reduced gamma-aminobutyric acid concentration is associated withphysical disability in progressive multiple sclerosis / N. Cawley, B.S. Solanky, N.Muhlert [et al.] // Brain. – 2015. – Vol. 138, Pt. 9. – P. 2584-2595.152. Celinski, K. Melatonin or L-tryptophan accelerates healing of gastroduodenalulcers in patients treated with omeprazole / K. Celinski, S.J. Konturek, P.C. Konturek[et al.] // J.
Pineal. Res. – 2011. – Vol. 50, № 4. – P.389-394.153. Cernysiov, V. Influence of circadian time and lighting conditions on expressionof melatonin receptors 1 and 2 in murine lymphocytes / V. Cernysiov, R. Bozaite, M.Mauricas [et al.] // In Vivo. –2014. - Vol. 28, № 5. - Р. 831-835.154. Cernysiov, V. The expression of MTNR3 and nuclear receptors in murineleucocytes / V. Cernysiov, R. Bozaite, M. Mauricas [et al.] // In Vivo. – 2014. –Vol. –24, № 5.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
